Canopy Growth Corporation announced an agreement to supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom, marking the company's official market entry into the UK. Under the agreement, the Canadian-grown flower will be supplied to GROW Group U.K. Ltd., a distributor of prescribed cannabis-based medicines across Europe. GROW Group will commercialize and distribute the products across the UK under Canopy Growth's global Spectrum Therapeutics medical brand. The expansion builds on the recent renewal of European Union Good Manufacturing Practice certification at Canopy Growth's cultivation facility in Kincardine, Ontario, which enables the company to export medical cannabis across European markets.
Canopy Growth CorpCanopy Growth signs a supply deal to enter the UK medical cannabis market, expanding end-customer distribution for its Spectrum Therapeutics products.
GROW Group gains a supply agreement to commercialize and distribute Canopy Growth's medical cannabis products across the UK.
